According to MeiraGTx's latest financial reports the company has $0.12 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.11 B | -16.11% |
2021-12-31 | $0.13 B | -34.28% |
2020-12-31 | $0.20 B | -7.8% |
2019-12-31 | $0.22 B | 233.77% |
2018-12-31 | $68.08 M | 696.39% |
2017-12-31 | $8.54 M | -51.09% |
2016-12-31 | $17.47 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Organovo ONVO | $5.29 M | -95.91% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.12 B | -3.21% | ๐ฌ๐ง UK |
Novavax NVAX | $0.56 B | 338.78% | ๐บ๐ธ USA |
Novocure
NVCR | $0.91 B | 602.82% | Jersey |